TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ALKS

Alkermes Plc

Healthcare · Drug Manufacturers - Specialty & Generic

40.90$ +0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ALKS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +1.5% +18.7% +21.1% +21.1% +7.0% -11.3% +13.0% -5.3% +49.6% -6.4% -5.2%
– -21.0% -4.9% +17.1% +14.0% +2.2% -1.1% +10.7% +10.5% +16.0% -3.0% -19.9%
– +10.5% +25.4% +22.0% +22.6% +7.9% -13.1% +13.5% -8.5% +57.8% -7.0% -2.5%
– +26.6% +12.4% +6.6% +3.0% +20.6% -23.1% -26.3% -6.3% -0.7% -9.4% +32.1%
– +55.9% +20.1% +12.7% +24.9% +8.0% -9.7% -0.5% -61.1% +0.5% -0.3% +213.9%
– +34.6% +15.2% +9.0% +13.4% +14.7% -16.6% -9.7% +2.4% +10.7% -10.5% +15.0%
– – – – – – – – -106.2% – +1.6% -39.6%
– -1.4% +12.4% -19.3% +28.6% -11.9% -36.3% +29.6% +16.2% +76.6% -2.0% -45.6%
– – – – – – – – -135.5% – +5.3% -34.3%
– -80.3% -288.2% – -15.9% -103.5% – -20.9% -82.1% -4,924.0% – -30.5%
– – – – – – – – – – +3.2% -34.2%
– -228.4% – – – – – – -66.3% +769.1% -4.7% -33.1%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?